CASI Pharmaceuticals CASI reported its Q4 earnings results on Monday, March 28, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
CASI Pharmaceuticals beat estimated earnings by 33.33%, reporting an EPS of $-0.04 versus an estimate of $-0.06.
Revenue was up $4.34 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 2.86% increase in the share price the next day.
Here's a look at CASI Pharmaceuticals's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -0.05 | -0.07 | -0.06 | -0.07 |
EPS Actual | -0.07 | -0.05 | -0.11 | -0.12 |
Revenue Estimate | 7.54M | 6.02M | 5.05M | 4.45M |
Revenue Actual | 8.11M | 7.16M | 5.74M | 4.82M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.